Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

42.9%

3 terminated/withdrawn out of 7 trials

Success Rate

57.1%

-29.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

150%

6 of 4 completed trials have results

Key Signals

6 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06229639Not ApplicableCompleted

Safety of the Nocturnal Passy Muir Valve and Impact on Sleep Quality at an LTACH Setting

Role: lead

NCT04930822Not ApplicableCompleted

Evaluation of Bioness Integrated Therapy System (BITS) Touch Screen Technology to Improve Field Awareness

Role: lead

NCT04941456Not ApplicableCompleted

Does Endurance Improve With the Use of Passy-Muir Valve for Patients With Tracheostomy?

Role: lead

NCT05617911Not ApplicableTerminated

Clinical Comparison of Patellofemoral Pain Syndrome Outcomes After Blood Flow Restriction Therapy

Role: lead

NCT05110300Not ApplicableTerminated

A Multisite Exploration of Balance Perturbations With and Without Body Weight Support

Role: lead

NCT05948501Withdrawn

The Effects of Concussion on Gait and Posture in Individuals With Peripheral Vision Loss

Role: lead

NCT04919161Not ApplicableCompleted

Explorations of the Benefits of the ZeroG TRiP System to Improve Balance in Patients Following Stroke

Role: lead

All 7 trials loaded